NIAID, along with other NIH institutes and centers (ICs), issued Notice of Special Interest (NOSI): An Annual Scientific Meeting to Support the Chemical Countermeasures Research Program (CCRP), which invites applicants to organize a series of annual in-person scientific meetings, conferences, symposia, and workshops to advance innovations in therapeutic and chemical toxicology research within the mission of the CCRP.
The CCRP, established by NIAID in 2006, is a trans-NIH initiative that supports basic research to better understand the fundamental toxic mechanisms of Chemicals of Concern (CoC) and advance discovery and development of medical countermeasure (MCM) products and strategies to prepare, respond, and recover from disasters and public health emergencies resulting from natural, accidental, and intentional release of these highly toxic substances.
Meeting Objectives
The primary goal of these annual scientific meetings—the first of which is expected to take place in 2026—is to provide a forum for the exchange of scientific data and ideas; foster collaboration between scientists at difference institutions and career stages; and provide career development and education opportunities for young scientists.
Successful applicants will work closely with CCRP program officials to ensure the R13 award will foster innovation and discussions to advance fundamental knowledge of CoCs' toxicities and stimulate research toward discovery and development of new or repurposed products as potential MCMs.
With almost 200 CoCs identified to date, applicants are encouraged to implement an interdisciplinary team science approach, while also demonstrating an ability to work cooperatively and collaboratively across multiple institutions.
Applicants must take steps toward openness and transparency such as recording the meetings, posting them online, and promoting them. To that end, we encourage applications to include an implementation plan for encouraging broad participation and recommend that applicants propose additional topics and creative approaches to maximize the outreach and impact of the meetings.
Finally, we strongly encourage prospective applicants to review the Conference Awards SOP prior to submission and contact NIAID’s scientific/research staff early to verify the consistency and scope of your intended application with the goals of this NOSI.
Application and Submission Information
You can submit applications for this initiative using the notice of funding opportunity (NOFO) NIH Support for Conferences and Scientific Meetings (Parent R13, Clinical Trial Not Allowed) or any subsequent reissues of the NOFO through the expiration date of the NOSI. All instructions in the SF 424 (R&R) Application Guide and the NOFO used for submission must be followed, with the following addition: Include “NOT-AI-24-066” (without quotation marks) in the Agency Routing Identifier field (box 4B) of the SF 424 R&R form. Applications without this information in box 4B will not be considered for this initiative.
NIH will award up to $70,000 in annual direct costs and no more than 5 years of support for the proposed series of annual meetings. Applicants may request full or partial NIH support for the proposed annual scientific meetings.
The first available due date for this NOSI is December 12, 2024; we will accept applications on NIH’s standard due dates through September 8, 2027.
Contact
For questions, contact Dr. Dave Yeung at dy70v@nih.gov or 301-796-7237.